Back

Summary and conclusions.

1 May 2017 (13:55 - 14:00)
Organised by:
Congress Presentation Part of: Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels Miscellaneous HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Presentation thumbnail
RAASi therapy benefit and challenges in cardio-renal patients.
Professor L. Lund (Stockholm, SE)
Presentation thumbnail
Treatment strategies to manage hyperkalemia and control potassium levels.
Professor S. Anker (Berlin, DE)
Presentation thumbnail
Changing the treatment paradigm of hyperkalemia management to enable and optimize RAASi therapy.
Professor J. Butler (Dallas, US)
Presentation thumbnail
Panel discussion.
Professor B. Pitt (Ann Arbor, US)

Access the full session

Session thumbnail
Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 13:55 CET
You may be interested in
thumbnail
Congress Presentation
Optimising heart failure treatment in patients receiving renal replacement therapy: the role of a cardiorenal unit
9 May 2026
thumbnail
Congress Presentation
Closing.
27 August 2022
thumbnail
Congress Presentation
Edoxaban in dialysis: a 4-year follow-up in a single center experience
26 August 2022
thumbnail
Congress Presentation
Hypophosphatemia in HFrEF patients after iron supplementation. Ferric carboxymaltose vs Ferric derisomaltose
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources